[ASAP] Enantioselective Bioreduction of Medicinally Relevant Nitrogen-Heteroaromatic Ketones
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00114 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 10, 2023 Category: Chemistry Authors: Wen-Ju Bai, Michelle A. Estrada, Jackson A. Gartman, and Andrew S. Judd Source Type: research
[ASAP] Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00004 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 10, 2023 Category: Chemistry Authors: Can Yong, Jianglin Yu, Chunxia Wu, Xiujuan Zhang, Yun Li, Chuan Xie, Xiaolong He, Dongfang Liu, Zhouyu Wang, Peng Lai, and Yuanyuan Zhang Source Type: research
[ASAP] Discovery of Selective and Potent KRAS < sup > G12D < /sup > Inhibitors as Potential Therapy in Cancer
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00167 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 10, 2023 Category: Chemistry Authors: Robert B. Kargbo Source Type: research
[ASAP] Covalent < italic toggle="yes" > S < /italic > ‑Adenosylhomocysteine-Based DNA Methyltransferase 2 Inhibitors with a New Type of Aryl Warhead
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00062 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 9, 2023 Category: Chemistry Authors: Marvin Schwickert, Robert A. Zimmermann, Tanja Habeck, Sabrina N. Hoba, Zarina Nidoieva, Tim R. Fischer, Martin M. Stark, Christian Kersten, Frederik Lermyte, Mark Helm, and Tanja Schirmeister Source Type: research
[ASAP] Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00094 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 8, 2023 Category: Chemistry Authors: Mudasir Nabi Peerzada, Daniela Vullo, Niccolo ̀ Paoletti, Alessandro Bonardi, Paola Gratteri, Claudiu T. Supuran, and Amir Azam Source Type: research
[ASAP] Drug Discovery and the Supramolecular Factor
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00157 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 6, 2023 Category: Chemistry Authors: Steven L. Regen Source Type: research
[ASAP] DNA-Encoded Macrocyclic Peptide Libraries Enable the Discovery of a Neutral MDM2 –p53 Inhibitor
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00117 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 5, 2023 Category: Chemistry Authors: Anthony P. Silvestri, Qi Zhang, Yan Ping, Erik W. Muir, Jingsi Zhao, Sai Kumar Chakka, Gaonan Wang, Walter M. Bray, Wenhua Chen, Jennifer L. Fribourgh, Sarvind Tripathi, Yunyun He, Seth M. Rubin, Alexander L. Satz, Cameron R. Pye, Letian Kuai, Wenji Su, a Source Type: research
[ASAP] Antimicrobial Peptides Incorporating Halogenated Marine-Derived Amino Acid Substituents
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00093 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 4, 2023 Category: Chemistry Authors: Alexander J. Craig °, Yuri Ermolovich°, Alan Cameron, Agnes Rodler, Helen Wang, Jeffrey A. Hawkes, Madlen Hubert, Fredrik Björkling, Natalia Molchanova△, Margaret A. Brimble, Lindon W. K. Moodie▼, and Johan Svenson Source Type: research
[ASAP] Increasing Underrepresented Minorities in STEM through Advocacy in Art
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00145 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 3, 2023 Category: Chemistry Authors: Paola Ariza-Storch Source Type: research
[ASAP] Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong < italic toggle="yes" > In Vivo < /italic > Anticancer Activity
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00470 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 3, 2023 Category: Chemistry Authors: Wei Hou, Zhao Chen, Chuqiao Pan, Maowei Ni, Haoqiang Ruan, Jun Song, Shiying Lu, Aman Bhasin, and Benfang Helen Ruan Source Type: research
[ASAP] An Automated, Open-Source Workflow for the Generation of (3D) Fragment Libraries
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00503 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 2, 2023 Category: Chemistry Authors: Tom Dekker, Mathilde A. C. H. Janssen, Christina Sutherland, Rene W. M. Aben, Hans W. Scheeren, Daniel Blanco-Ania, Floris P. J. T. Rutjes, Maikel Wijtmans, and Iwan J. P. de Esch Source Type: research
[ASAP] High-Throughput Photo- and Electrochemical sp < sup > 2 < /sup > –sp < sup > 3 < /sup > Cross-Electrophile Coupling to Access Novel Tedizolid Analogs
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00542 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - May 1, 2023 Category: Chemistry Authors: Jose Raul Montero Bastidas, Scott L ’Heureux, Wenbin Liu, Ken Lee, and Abdellatif El Marrouni Source Type: research
[ASAP] Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00089 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - April 27, 2023 Category: Chemistry Authors: Sandip Guchhait, Alina Khononov, Tomasz Pien ́ko, Valery Belakhov, and Timor Baasov Source Type: research
[ASAP] Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00140 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - April 26, 2023 Category: Chemistry Authors: Ram W. Sabnis Source Type: research
[ASAP] Novel Imidazotriazine Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune Disorders
ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00139 (Source: ACS Medicinal Chemistry Letters)
Source: ACS Medicinal Chemistry Letters - April 25, 2023 Category: Chemistry Authors: Ram W. Sabnis Source Type: research
